tirzepatide news - Search News

FDA, Tirzepatide

INSIDER on MSN · 3d

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

FOX News on MSN · 2d

FDA approves first medication for obstructive sleep apnea — which also promotes weight loss

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

NBC News on MSN · 8d

FDA says tirzepatide shortage is over after taking a second look

The FDA said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli Lilly’s diabetes and weight loss drugs Mounjaro and Zepbound — is over.

FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to companies making cheaper copies.

The Indian Express · 2d

US FDA approves use of weight loss drug for sleep apnoea: Here’s all you need to know

The drug has been approved for use in combination with a low-calorie diet and increased physical activity in those with moderate to severe OSA. This shows that the weight-loss drug has multifarious uses other than controlling type-2 diabetes and obesity.

1don MSN

The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

AOL23h

What is Compounded Tirzepatide? Here's What You Need to Know

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re starting a weight loss journey, you might have ...

Everyday Health6h

FDA Approves First Medication for Obstructive Sleep Apnea

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

3d

Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

3don MSN

FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

MedPage Today8d

FDA Says Compounded Tirzepatide Must Exit the Market

Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...

1don MSN

Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

Psychology Today13h

GLP-1RAs in People With Higher Weight and Eating Disorders

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

1d

‘An insatiable itch’: Why some people are turning to weight-loss medications to help quiet food noise

Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results